Philippines
Tuberculosis profile
| High TB burden | High MDR-TB burden |
Population  2012 97 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 23 (22–25) 24 (22–26)
Mortality (HIV+TB only) 0.11 (0.09–0.13) 0.11 (0.09–0.14)
Prevalence  (includes HIV+TB) 450 (390–500) 461 (405–520)
Incidence  (includes HIV+TB) 260 (210–310) 265 (219–316)
Incidence (HIV+TB only) 0.46 (0.38–0.55) 0.48 (0.39–0.57)
Case detection, all forms (%) 84 (71–100)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 94 006 (44) Relapse 4 084 (23)
Smear-negative 115 263 (54) Treatment after failure 591 (3)
Smear-unknown / not done 0 (0) Treatment after default 1 246 (7)
Extrapulmonary 3 274 (2) Other 11 698 (66)
Other 0 (0)      
Total new 212 543   Total retreatment 17 619  
           
Other (history unknown) 0        
Total new and relapse 216 627   Total cases notified 230 162  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.3 1.6 1.2
Age < 15 1 049    
Laboratories 2012
Smear (per 100 000 population) 2.7
Culture (per 5 million population) 0.7
Drug susceptibility testing (per 5 million population) 0.2
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 90   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 85  
Retreatment 65  
TB/HIV 2012 Number (%)
TB patients with known HIV status 2 040 (<1)
HIV-positive TB patients 4 (<1)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4 (2.9–5.5) 21 (14–29)
MDR-TB cases among notified pulmonary
TB cases
8 500 (6 000–11 000) 3 700 (2 500–5 100)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 35 (<1%) 2 038 (12%) 2 107
Laboratory-confirmed MDR-TB cases 11 653 679
Patients started on MDR-TB treatment     1 918
Financing TB control 2013
National TB programme budget (US$ millions) 149
% Funded domestically 16%
% Funded internationally 15%
% Unfunded 69%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data